
USA - NASDAQ:IMMU -
ChartMill assigns a Buy % Consensus number of 77% to IMMU. The Buy consensus is the weighted average rating of the current analysts ratings.
The consensus rating for Immunomedics Inc (IMMU) is 77.2 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering Immunomedics Inc (IMMU) is 7.